Damon Willems (D Willems)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Hidradenitis Suppurativa

Top Venues

Journal of medical economics

PharmacoEconomics

Archives of osteoporosis

This page only lists publications with an associated author ORCID identifier.

Publications

Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Damon Willems, C J Sayed, H H Van der Zee, J R Ingram, E Hinzpeter, C Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United States. Journal of medical economics (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient (2023)
Valgerdur Sigurdardottir, Anna Engstrom, Patric Berling, Tor Olofsson, Linnea Oldsberg, Susannah Sadler, Devian Parra-Padilla, Lode Melis, Damon Willems
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden. Journal of medical economics (2023)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Isabell Wiethoff, Mickaël J C Hiligsmann
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review. PharmacoEconomics (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Katja C Heinz, Damon Willems, Mickaël J C Hiligsmann
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective. Journal of medical economics 25 (1) (2022)
Ron Goeree, Natasha Burke, Manon Jobin, Jacques P Brown, Donna Lawrence, Björn Stollenwerk, Damon Willems, Ben Johnson
Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada. Archives of osteoporosis 17 (1) (2022)
Damon Willems, Mickaël J C Hiligsmann, Hessel H van der Zee, Christopher J Sayed, Silvia M A A Evers
Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study. The patient (2021)